Kutluk Oktay, M.D. is a professor of obstetrics & gynecology and the director of the division of reproductive medicine & infertility at New York Medical College. He is also the medical director of the Institute for Fertility Preservation at the Center for Human Reproduction in New York City (www.fertilitypreservation.org). Dr. Oktay is a pioneer in the field of reproductive medicine and infertility and in fertility preservation.
After earning his M.D. degree at the Hacettepe University School of Medicine in Ankara, Turkey, he trained in internal medicine at Marmara University Medical School, Istanbul, Turkey, and Cook County Hospital, Chicago, Illinois. He then completed his obstetrics and gynecology residency at the University of Connecticut Health Center and subspecialty training in reproductive endocrinology and infertility at the University of Texas Health Science Center at San Antonio. Dr. Oktay was then awarded a fellowship at the University of Leeds Assisted Reproduction Unit in England.
Dr. Oktay developed and performed the world’s first ovarian transplantation procedures with frozen-banked ovarian tissue and has invented novel ovarian stimulation protocols for cancer patients undergoing embryo and egg freezing. Dr. Oktay has recently received a research grant from the National Institute of Health to study the impact of chemotherapy on ovarian reserve and was invited to the President’s Cancer Panel as an expert on fertility preservation. In addition, he is the co-chair of the American Society of Clinical Oncology Committee for Fertility Preservation Guidelines for People with Cancer. Dr. Oktay has also conducted key work on the early stages of ovarian follicle and embryo development, as well as on controlled ovarian stimulation and in vitro fertilization.
Dr. Oktay has published over 80 articles and book chapters. He gives lectures around the world and has been recognized with numerous scientific and clinical awards. He has been named one of the top doctors in the U.S. and in the New York metropolitan area. "What Breastcancer.org offers is outstanding," says Dr. Oktay, "and I am honored to be able to contribute to this extremely helpful resource."
Can we help guide you?
Create a profile for better recommendations
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
Cancer Survivors Overestimate Quality of Their Diets
Most people who have been diagnosed with cancer think they eat a healthy diet, but a study found...